Is it possible to stop or alter the patient's medication, specifically lorazepam (Ativan), while awaiting a referral?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lorazepam Be Safely Stopped or Altered While Awaiting Referral?

Do not abruptly stop lorazepam—this can cause life-threatening withdrawal reactions including seizures, and you must implement a gradual taper even while awaiting specialist referral. 1

Critical Safety Considerations

Abrupt discontinuation of lorazepam is dangerous and contraindicated. The FDA label explicitly warns that sudden cessation can precipitate acute withdrawal reactions that are potentially life-threatening, including seizures, severe mental status changes, and suicidal ideation 1. Physical dependence develops with continued benzodiazepine use, and withdrawal symptoms can emerge within hours to days after stopping 1.

Withdrawal Risk Factors

Patients at highest risk for severe withdrawal include those who 1:

  • Take higher dosages of lorazepam
  • Have used the medication for longer durations
  • Have concurrent use of other CNS depressants

Recommended Approach While Awaiting Referral

Initiate a gradual taper using a patient-specific plan rather than continuing the current dose unchanged. 1 The American Geriatrics Society emphasizes that stopping CNS-active medications requires particular caution and should generally be done one medication at a time 2.

Tapering Strategy

  • Reduce the dose gradually rather than maintaining status quo—even a slow taper is preferable to abrupt discontinuation later 2, 1
  • Monitor closely for withdrawal symptoms including anxiety, insomnia, tremor, confusion, and seizures 1, 3
  • Document the rationale for any medication changes and the tapering plan 2

Specific Withdrawal Phenomena to Anticipate

Lorazepam withdrawal produces distinct patterns 3:

  • Rebound insomnia peaks around the third night after discontinuation and can be several times worse than baseline sleep disturbance 3
  • Increased daytime anxiety and tension emerge even with continued use and worsen during withdrawal 3
  • Protracted withdrawal syndrome can last weeks to over 12 months in some patients, with symptoms including anxiety, memory problems, depression, and sensory disturbances 1

Alternative Management Options

If you cannot prescribe alternative formulations or routes, focus on optimizing the current oral regimen while implementing a conservative taper. 2 The key is avoiding both therapeutic abandonment and dangerous abrupt cessation.

Considerations for Dose Reduction

  • Start with the lowest effective reduction (typically 10-25% of the current dose every 1-2 weeks) 1
  • Extend the taper timeline if withdrawal symptoms emerge—slower is safer 2, 1
  • Consider splitting doses to maintain more stable blood levels during the taper 1

When Continuation May Be Appropriate

The American Geriatrics Society acknowledges that for older adults with multimorbidity, decisions about stopping medications must weigh 2:

  • Time horizon to benefit versus harm
  • Patient's remaining life expectancy
  • Risk of withdrawal complications versus ongoing medication risks
  • Complexity of the overall medication regimen

If the referral timeline is short (days to weeks) and the patient is stable, maintaining the current dose with close monitoring may be reasonable while awaiting specialist input. 2 However, document this decision and the plan for specialist evaluation clearly.

Common Pitfalls to Avoid

  • Never assume benzodiazepines can be stopped like other medications—they require specialized tapering protocols 1
  • Do not mistake withdrawal-induced agitation for inadequate dosing—this can lead to dose escalation rather than appropriate tapering 2
  • Avoid adding multiple new medications to manage withdrawal symptoms without first addressing the underlying benzodiazepine dependence 2
  • Do not delay initiating a taper simply because you cannot prescribe alternative formulations—oral tapering is still feasible and necessary 1

Documentation and Communication

Clearly document your assessment, the risks of both continuation and discontinuation, and your management plan. 2 Communicate with the referral specialist about:

  • Current lorazepam dose and duration of use
  • Any tapering already initiated
  • Withdrawal symptoms observed
  • Patient's understanding and preferences regarding medication changes

The goal is to bridge safely to specialist care without creating additional harm through either abrupt cessation or indefinite continuation without a plan.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.